Breaking News
Top News
-
Jim Cramer on ImmunityBio: “I Would Encourage You to Own It, Provided You Don’t Own Any Other Spec”
-
Jim Cramer on Capital One Financial: “We’re Going to Continue to Own Ours”
-
Jim Cramer on Venture Global: “I Think It Can Go Much Higher”
-
Jim Cramer on Oscar Health: “I Would Start Buying It Here, Buy Some, I’d Buy Half Here, and Then Buy Half at $9 If It Gets There”
-
Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All”
-
J.Jill, Inc. Q4 2025 Earnings Call Summary
-
Bitfarms Ltd. Q4 2025 Earnings Call Summary
-
FactSet Research Systems Inc. Q2 2026 Earnings Call Summary
-
McCormick & Company, Incorporated Q1 2026 Earnings Call Summary
-
TD SYNNEX Corporation Q1 2026 Earnings Call Summary
-
T1 Energy Inc Q4 2025 Earnings Call Summary
-
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary
-
Corn Bouncing Following Positive Stocks Data
-
Soybeans Rallying as Acres Seen Lower than Expected
-
KuCoin Hit with Permanent U.S. Ban and $300M in Penalties
-
Judge Dismisses Lawsuit That Challenged Ban on Endorsements by Churches
-
Iran War Showcases Strength of South Korean Defense Sector
-
Metals Fall as Trump Repeats Threat to Attack Iran Power Plants
-
India Trading Ban Rocks $149 Billion-a-Day Offshore Rupee Market
-
Trump Threatens to Escalate War in Iran Even As End Is “Close”
2026-02-05
































